Compile Data Set for Download or QSAR
maximum 50k data
Found 98 with Last Name = 'trübel' and Initial = 'h'
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190298(US9180120, 2)
Affinity DataIC50:  1nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190302(US9180120, 6)
Affinity DataIC50:  1nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192452(US9187466, 50 | US9687476, 50)
Affinity DataIC50:  1.40nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192451(US9187466, 49 | US9687476, 49)
Affinity DataIC50:  1.5nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192449(US9187466, 32 | US9687476, 32)
Affinity DataIC50:  2nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190348(US9180120, 52)
Affinity DataIC50:  2nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190343(US9180120, 47)
Affinity DataIC50:  2nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190338(US9180120, 42)
Affinity DataIC50:  3nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192468(US10800746, Example WO 2011/104322 110 | US9187466...)
Affinity DataIC50:  3.30nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190309(US9180120, 13)
Affinity DataIC50:  4nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)
Affinity DataIC50:  4nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190349(US9180120, 53)
Affinity DataIC50:  4nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192456(US9187466, 71 | US9687476, 71)
Affinity DataIC50:  4.20nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192467(US10800746, Example WO 2011/104322 101 | US9187466...)
Affinity DataIC50:  4.40nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192473(US9187466, 132 | US9687476, 132)
Affinity DataIC50:  4.60nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190343(US9180120, 47)
Affinity DataIC50:  5nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190321(US9180120, 25)
Affinity DataIC50:  5nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190305(US9180120, 9)
Affinity DataIC50:  5nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192474(US9187466, 135 | US9687476, 135)
Affinity DataIC50:  5.80nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192468(US10800746, Example WO 2011/104322 110 | US9187466...)
Affinity DataIC50:  6.5nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192453(US10800746, Example WO 2011/104322 54 | US9187466,...)
Affinity DataIC50:  6.80nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190348(US9180120, 52)
Affinity DataIC50:  7nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192469(US9187466, 111 | US9687476, 111)
Affinity DataIC50:  7.70nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190329(US9180120, 33)
Affinity DataIC50:  8nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190321(US9180120, 25)
Affinity DataIC50:  8nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190338(US9180120, 42)
Affinity DataIC50:  8nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US10800746, Example WO 2011/104322 68 | US9187466,...)
Affinity DataIC50:  8.30nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192466(US9187466, 96 | US9687476, 96)
Affinity DataIC50:  8.40nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192453(US10800746, Example WO 2011/104322 54 | US9187466,...)
Affinity DataIC50:  8.5nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192449(US9187466, 32 | US9687476, 32)
Affinity DataIC50:  8.60nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190306(US9180120, 10)
Affinity DataIC50:  9nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190353(US9180120, 57)
Affinity DataIC50:  10nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190335(US9180120, 39)
Affinity DataIC50:  10nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)
Affinity DataIC50:  11nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190315(US9180120, 19)
Affinity DataIC50:  11nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192454(US10800746, Example WO 2011/104322 60 | US9187466,...)
Affinity DataIC50:  12nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US10800746, Example WO 2011/104322 68 | US9187466,...)
Affinity DataIC50:  12nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192463(US9187466, 87 | US9687476, 87)
Affinity DataIC50:  12nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190302(US9180120, 6)
Affinity DataIC50:  12nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190315(US9180120, 19)
Affinity DataIC50:  13nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190332(US9180120, 36)
Affinity DataIC50:  13nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192456(US9187466, 71 | US9687476, 71)
Affinity DataIC50:  13nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190355(US9180120, 59)
Affinity DataIC50:  14nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190349(US9180120, 53)
Affinity DataIC50:  15nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190298(US9180120, 2)
Affinity DataIC50:  16nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190329(US9180120, 33)
Affinity DataIC50:  17nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192458(US9187466, 76 | US9687476, 76)
Affinity DataIC50:  17nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190363(US9180120, 67)
Affinity DataIC50:  18nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM190332(US9180120, 36)
Affinity DataIC50:  19nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192451(US9187466, 49 | US9687476, 49)
Affinity DataIC50:  19nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 98 total ) | Next | Last >>
Jump to: